Sitemap

Post Content

Search Medicilon

Medicilon Highlights at the 2025 CBA-China Conference

Medicilon Supports BIOTIME in Securing Dual China-US Approvals for CDC7 Inhibitor BIOT-006

BIK Therapeutics and Medicilon Sign Strategic Collaboration Agreement to Accelerate Oncology Drug Innovation.

Contact Medicilon

Name
Address